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Chapter 1: Introduction 
 
General introduction 
Due to the advancement of science and technology especially in medical science, the 
average life span of the population all over the world has been increased. The global population 
over 60 years old was 382 million in 1980, which increased more than double in 2017 to 962 
million. This elderly population will be expected to double again in 2050 to nearly 2.1 billion. 
On the other hand, the population aged over 80 years will become triple from the present 137 
million to 425 million in 2050. At present Japan has the world’s largest aged population over 
60 years which is 33.4% of Japan’s total population and it will also remain in the top country 
list in 2050 (42.4%) [1]. The process of aging is associated with the onset of many diseases 
such as cardiovascular diseases, hypertension, diabetes, osteoporosis hypogonadism, and 
neurodegenerative diseases [2]. As a result of population aging the health cost for elderly 
people is increasing day by day all over the world. As Japan has the highest number of aged 
people with respect to its population, per capita health cost for the elderly people is also the 
highest in Japan. This cost will also increase in the near future [1]. Therefore, effective 
measures should be taken now to prevent age-related diseases for improving the healthy 
lifespan. 
With aging testosterone synthesis declines in the male that is defined as late onset 
hypogonadism. Several diseases are also associated with the onset of hypogonadism. 
Moreover, testosterone exerts many physiological functions in various organs to ameliorate 
many diseases [3]. Testosterone replacement therapy (TRT) to restore the testosterone level 
especially for elderly men has been popularly used as a medication. However, TRT has been 
reported with several adverse effects such as cardiovascular disease, prostate cancer, lower 
urinary tract symptoms, obstructive sleep apnea, and erythrocytosis [4,5]. Therefore, it is 
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important to search for safe medications or natural bioactive compounds to boost testosterone 
levels for elderly men or prevent hypogonadism in healthy men. 
Neurodegenerative diseases are a heterogeneous group of disorders involved in 
progressive loss and damage of neurons in the brain leading to cognitive and functional decline 
over time. Age is the primary risk factor for neurodegenerative diseases such as Alzheimer’s 
disease, Parkinson's disease, and Huntington’s disease. Currently, there is no medicine to cure 
Alzheimer’s diseases and Parkinson's diseases, only some drugs are effective to ameliorate the 
symptoms. Oxidative stress has been implicated in these neurodegenerative diseases and 
several antioxidants have been reported experimentally and clinically to ameliorate these 
diseases [6,7]. 
To prevent and cure age-related diseases and reduce the cost burden, the search for 
bioactive compounds from natural sources with therapeutic potential is gaining research 
interest. Natural bioactive compounds are very easy to extract and therefore very cheap. 
Moreover, numerous natural compounds are being used traditionally in many cultures as 
therapeutic agents which are relatively less toxic and safe [8,9]. To this direction the present 
study focused on a bioactive compound S-allyl cysteine, exclusively found on garlic, to 
evaluate its role in testosterone synthesis and protection from neurotoxicity.  
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Purpose of the study 
 
The principal purpose of the study is to analyze the health beneficial effects of S-allyl 
cysteine (SAC). To evaluate these effects, two major studies were accomplished: 
1. Effect of SAC on testosterone production was explored in cell and animal-based 
experiments. 
2. Neuroprotective effect of SAC was investigated using mouse hippocampal-derived HT-22 
cells after glutamate-induced neurotoxicity.  
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S-allyl cysteine  
S-allyl cysteine (SAC) is a bioactive sulfur-containing amino acid derivative found in 
garlic along with other sulfur-containing compounds (Figure 1). SAC has been reported to have 
antioxidant, anticancer, and neuroprotective properties in numerous animals and cell-based 
studies. SAC, both from chemically synthesized and garlic extracted, is a white crystalline 
powder at room temperature and has a characteristic odor. SAC is soluble in water (68mg/mL), 
has a melting temperature of 222-224°C, and highly stable compound in various physiological 
conditions [10]. 
SAC is found in fresh garlic at a very low amount that is 20-30 µg/g fresh garlic. Its 
content in garlic can be increased by a chemical process called the aging of garlic. In this 
process, garlic cloves are soaked in 15-20% aqueous ethanol for several months in a stainless 
still tank at room temperature.  γ-Glutamyl-S-allyl cysteine, present at a high amount in garlic, 
is completely hydrolyzed to SAC by the enzyme γ-glutamyl transpeptidase (Figure 2). In this 
process, the amount of SAC can be increased from 0.2 mg/g dry extract to 7.2 mg/g dry extract 
after 24 months [11]. Black garlic is another form of preparation where the amount of SAC in 
garlic can be enhanced. Black garlic is prepared by heat treatment of whole bulbs of raw garlic 
at high temperature and high humidity for several days [12].  Studies showed that the amount 





Potential role of SAC as an antioxidant 
The earlier studies on SAC were reported principally on its antioxidant properties. SAC 
is the most abundant compound of aged garlic extract (AGE) preparation. AGE was initially 
discovered for the protection of various organs such as heart, liver, and kidney from oxidative 
injury. Later it was found that the antioxidant property of AGE was mostly due to the abundant 
presence of SAC on it [14,15]. The earlier studies suggested that SAC can suppress reactive 
oxygen species, superoxides, hydroxyl free radicals, and peroxynitrite generations. SAC also 
has been reported to prevent lipid and protein oxidation and nitration. SAC can upregulate the 
antioxidant enzymes and suppress the prooxidant enzymes via activating the transcription 
factor Nrf2 [16]. Various animal studies suggested the involvement of antioxidant activity of 
SAC to ameliorate diabetes, kidney injury, and liver injury [17,18,19]. The protective effects 
of SAC on male reproductive organs via its antioxidant activity also have been reported in 
various animal models. In a streptozotocin-induced diabetic rat model, SAC restored erectile 
dysfunction via reducing the reactive oxygen formation through modulation of NADPH 
oxidase subunit expression [20]. Another study showed that after long-term supplementation 
of SAC in aged rats, SAC can improve the age-related reduction of the sperm number, motility, 
and DNA synthesis through inhibition of oxidized proteins [21]. Furthermore, a recent study 
on boar spermatozoa revealed that SAC improved motility, plasma membrane integrity, and 
mitochondrial activity of boar sperm [22].  
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Role of SAC in neurodegenerative diseases 
Numerous studies on animal and cell-based experiments have been reported on the 
neuroprotective effect of SAC.  A comparative study on various sulfur-containing compounds 
from garlic showed that SAC was the most potent compound to have a neurotrophic effect. 
SAC at a very low concentration (100 ng/mL) could enhance the survival of neurons isolated 
from rat brain and increased the branching of axons of neurons [23]. Amyloid β proteins 
aggregation in the central nervous system is the main cause of pathogenesis of Alzheimer’s 
diseases resulting in neuronal cell loss in the brain [24]. A cell-based study showed that SAC 
selectively protected differentiated PC12 cells, a neuronal cell model, from amyloid β (Aβ) 
induced cell death. Interestingly, SAC did not show this effect on undifferentiated PC12 cells, 
suggesting its selective role in neuroprotection [25]. Similarly, in another study, SAC showed 
neuroprotective effects on isolated rat hippocampal neurons from Aβ and tunicamycin-induced 
neurotoxicity [26]. A cell-free system-based study demonstrated that SAC dose-dependently 
inhibited Aβ fibrillation and destabilized preformed Aβ fibrils [27]. In a streptozotocin-induced 
mice model, pretreated with SAC showed amelioration of cognitive and neurobehavioral 
impairments. SAC also reduced DNA fragmentation, apoptosis-inducing protein marker, and 
oxidative stress in the hippocampus of these mice [28]. In another mice model, SAC showed 
protective effect on the brain after D-galactose induced brain injury via restoring various 
antioxidant enzymes and reducing Aβ proteins level in the brain [29]. Furthermore, several 
studies on animal models of various neurodegenerative diseases such as stroke, Huntington 




Testosterone and its function  
Testosterone is the principal sex hormone in males responsible for developing primary 
and secondary sex characteristics. Testosterone plays a key role to maintain male fertility and 
spermatogenesis. Over aging males develop the late onset of hypogonadism which is 
characterized by low testosterone synthesis in the Leydig cell of testis [30]. A population-based 
study showed that male starts to decrease blood testosterone level from their middle-age by 2% 
per year [31]. Low testosterone level is associated with the development of various diseases 
such as osteoporosis, type 2 diabetes, and cardiovascular diseases [3]. Testosterone and its 
metabolite dihydrotestosterone mediate their function via binding to the intracellular androgen 
receptor (AR) that acts as a transcription factor for many target genes. AR is widely expressed 
in the tissues of various organs like the brain, muscle, and pancreatic islets [32]. It is well 
established that in aging men decreased muscle mass and strength are restored by testosterone 
replacement [33]. Experimental animal models with muscle-specific knock-out of AR 
demonstrated that testosterone has a role in maintaining muscle mass and strength [34]. More 
recent data suggests that the maximal action on muscle and physical activity by testosterone is 
achieved by the AR in the neurons of the hypothalamus [35]. The Association of testosterone 
and bone mineral density also has been established. Testosterone therapy in elder men 
improves bone mineral density. Animal and cell base studies revealed that testosterone 
improves bone mineral density via AR on osteoclast and osteoblast cells. Moreover, estradiol, 
an aromatized metabolite of testosterone also plays role in bone function via the estrogen 
receptor on various cell types [36]. Observational studies reported that androgen deprivation 
therapy in prostate cancer patients causes obesity and type 2 diabetes. A recent study on animal 
models revealed that testosterone can improve insulin secretion in pancreatic β cells via 
extranuclear androgen receptor and glucagon-like protein 1 receptor [37]. Low level of 
testosterone also has been reported to be associated with fatigue, depression, loss of cognition, 
9 
  
and sleep disturbance [3]. Therefore, it is important to maintain physiological testosterone 
levels, especially in aging men to lead a healthy life.  
Mechanism of testosterone synthesis 
Testosterone is predominantly produced in the Leydig cell of testis in males (Figure 3). 
The testosterone synthesis pathway begins with the release of luteinizing hormone (LH) from 
the pituitary gland to the circulation. LH binds to its receptor on the cell surface of the Leydig 
cell that is a member of G-protein coupled receptors. Then the intracellular cAMP level is 
increased, protein kinase A (PKA) becomes activated to its phosphorylated form. Activated 
PKA targets the transcription factor CREB (cAMP responsive element binding protein) for the 
transcription of many genes involved in testosterone syntheses such as CYP11A and StAR.  
PKA also phosphorylates the StAR protein to its more active form. StAR proteins transfer 
cholesterol from the outer mitochondrial membrane to the inner mitochondrial membrane, and 
then CYP11A protein produces pregnenolone from cholesterol. In the smooth endoplasmic 
reticulum, pregnenolone is converted to progesterone and testosterone by other steroidogenic 
enzymes. [38]. 
Mechanism of glutamate-induced neurotoxicity in HT-22 cell  
Glutamate is one of the most important excitatory neurotransmitters and the most 
abundant amino acid in the brain. Glutamate participates in neural transmission, development, 
differentiation, and plasticity. Glutamate mediates its action via two types of receptors on 
neuronal cells named ionotropic receptors and metabotropic receptors. Ionotropic receptors 
include NMDA, AMPA, or kainate receptors that act as ion channels. On the other hand, 
metabotropic receptors are G-protein coupled receptors that activate second messenger 
cascades. Glutamate also can act on CySS/glutamate antiporter. It has been reported that in 
neurodegenerative diseases like Alzheimer’s disease and Parkinson's disease, the extracellular 
concertation of glutamate increases. In neuronal cells, overexcitation by glutamate mediates 
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the influx of Ca2+ ions leading to cell death via activation of various cellular events such as up-
regulation of nNOS, mitochondrial dysfunction, ROS production, ER stress, and release of 
lysosomal enzymes. [39]. 
HT-22 cells are mouse hippocampal-derived cell lines that are widely used as a model 
for glutamate-induced neurotoxicity studies. Though HT-22 cells do not have any functional 
glutamate receptors, excessive glutamate causes both necroptotic and apoptotic cell death in 
this cell. In HT-22 cells excessive intracellular glutamate blocks the influx of cystine via the 
cystine/glutamate transporter resulting in depletion of cysteine in the cell (Figure 4). 
Consequently, glutathione synthesis is compromised and cellular reactive oxygen species level 
increases both in the cytoplasm and mitochondria. This type of cell death is associated with 
mitochondrial fission. Mitochondria releases apoptosis-inducing factor and cytochrome c to 
the nucleus resulting in nuclear fragmentation and ladder formation. A previous comprehensive 
study suggested that this type of cell death is independent of caspase activation, although 
involvement of caspase 3 activation has been reported. Extracellular signal-related kinases 
(ERK) and other mitogen activated protein kinases (MAPK) like p-38 and JNK play a key role 
in glutamate-induced cell death in HT-22 cells. Prolonged activation of these MAPK proteins 





























































Chapter 2: Effect of S-allyl cysteine on testosterone production 
 
To confirm the effect of SAC on testosterone production, animal and cell-based 
experiments were conducted. For a single dose experiment, BALB/c mice and chronic dose 
experiment, Wistar rats were used. For cell-based experiment mouse testis-derived I-10 tumor 
cells were investigated. 
Study 1: Effect of S-allyl cysteine on testosterone production in mice after single dose 
administration 
 
Methods and materials 
SAC 
SAC was purchased from the Tokyo Chemical Industry Co., Ltd. (Tokyo, Japan). 
SAC was stored at room temperature.  
Animal experiment   
Six-week-old male BALB/c mice were purchased from CLEA Japan, Inc. (Tokyo, 
Japan). The mice were then maintained for 1 week in a 12 h/12 h dark/light cycle for 
acclimation. The mice had free access to the F-2 laboratory diet (Funabashi Farm Co., 
Funabashi, Japan) and tap water. After one week of acclimation, mice were divided into two 
groups (n=8 in each group). Mice of the treatment group were administered SAC 
intraperitoneally at a concentration of 50 mg/kg body weight in normal saline, whereas the 
mice of the control group were administered normal saline only. The final volume of the vehicle 
was at a ratio of 20 µL to 1 g of body weight of the mice. After 6 h of SAC administration, the 
mice were sacrificed. Blood from the heart was collected by heparinized 26.5G needles and 
testis were dissected for further analysis. For plasma collection, the blood was centrifuged at 
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2,000 x g for 15 min at 4°C. The supernatant was collected and stored at -65°C for further 
analysis.  
Testosterone extraction and measurement from plasma and testis 
Testosterone was measured from the testis and plasma by ELISA method according to 
the manufacturer’s instructions (Cayman Chemical Co., Ann Arbor, MI, USA). At first, testes 
were homogenized in phosphate-buffered saline (PBS) at a ratio of 100 mg testes to 5 mL PBS 
using a polytron homogenizer. Next, 1 mL of the testis homogenate or 200 µL of plasma was 
mixed with 5 times volume of diethyl ether in a glass test tube and centrifuged at 1500 × g for 
3 min. Approximately 90% of the upper ether layer was collected in another tube. This 
procedure was repeated three more times. The collected ether layer was evaporated using a 
vacuum evaporator (Spin Dryer Light VC-36R, TAITEC Corp., Saitama, Japan) at 1800 rpm, 
30°C.  After evaporation, the ELISA buffer supplied with the kit was added to the residue, and 
testosterone was measured from this solution. Testosterone level in testes was normalized with 
the amount of protein. 
Lowry method for protein quantification from testis 
Testis homogenate was centrifuged at 13,000 rpm for 5 min at 4°C. From the 
supernatant, protein amount was calculated by the Lowry method.  Bovine serum albumin was 
used as a protein standard. 80 µL sample or protein standard were mixed with 400 µL alkaline 
solution (2% Na2CO3 in 0.1 N NaOH and CuSO4·5H2O at a ratio of 50:1) and incubated at 
37°C for 10 min. Next, 40 µL of Follin reagent was mixed with each sample and incubated at 
37° C for 30 min. Absorbance was taken at 750 nm.  
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Luteinizing hormone measurement 
Luteinizing hormone (LH) levels in the plasma of BALB/c mice were measured by 
rodent LH test kit according to the manufacturer’s instructions (Endocrine Technologies, 
Newark, NJ, USA). Briefly, 50 µL LH standard or plasma was mixed with 100 µL enzyme 
conjugate in well supplied with the kit. and incubated for 2 h at 37°C. The mixture was 
removed, and the wells were washed by wash buffer five times. 100 µL of TMB solution was 
added to the wells and incubated for 20 min in the dark. 50 µL of 2 N HCl was added to stop 
the reaction. Then the absorbance was taken at 450 nm using an ELISA plate reader. 
Western blot method 
Testes were homogenized with PBS (at a ratio of 100 mg testes to 1 mL PBS) containing 
complete proteinase inhibitor cocktail, and PhosSTOP phosphatase inhibitor cocktail (Roche 
Applied Science, Mannheim, Germany) using polytron homogenizer. The homogenates were 
centrifuged at 13,000 rpm, 4°C for 5 min. Protein concentration from the supernatant was 
measured by the Lowry method as mentioned earlier in this section. Proteins from the 
supernatant were denatured in SDS gel loading buffer. 15 µg of proteins were resolved in 10–
20% SDS-polyacrylamide gel (Wako Pure Chemical Industries, Osaka, Japan) by 
electrophoresis at 150 V for 150 min. Proteins separated from the gel were transferred into 
polyvinylidene difluoride membranes (Millipore, Billerica, MA, USA). The membranes were 
blocked in TBS-T buffer (10 mM Tris-HCl at pH 7.5, 150 mM NaCl, and 0.1% Tween 20) 
containing 5% skim milk or 3% bovine serum albumin for 2 h. The membranes were then 
incubated overnight with blocking buffer containing an antibody against PKA, phosphorylated 
PKA (Cell Signaling Technology, Danvers, MA, USA), and CYP11A (Chemicon, Temecula, 
CA, USA) followed by horseradish peroxidase (HRP)-tagged secondary antibody incubation 
for 1 h. Antibodies against α-tubulin (Sigma-Aldrich) or β-actin (Abcam, Tokyo, Japan) were 
incubated for 1 h followed by an HRP-tagged secondary antibody incubation for 1h. HRP 
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substrate (Immobilon Western Detection Reagent, Millipore) was incubated with the 
membrane at room temperature to detect the immunoreactive bands. The bands were visualized 
using a LAS-4000 mini luminescent image analyzer (Fujifilm, Tokyo, Japan). Relative protein 
expression levels were measured by normalizing with the expression of α-tubulin or β-actin.  
Statistical analysis 
All the data presented in the figures are shown as mean ± standard error (SE). For the 
comparison of means between two groups, student’s t-test was performed. In the case of 
comparing the means of more than two groups, data were analyzed by one-way ANOVA or 
Dunnett’s test, or Tukey test. All the statistical analyses were performed using SigmaPlot 
version 12.5 (Systat Software Inc., San Jose, CA, USA) with a significance level of α = 0.05. 
P<0.05 is considered statistically significant. 
 
Results: 
After the single dose of SAC administration in BALB/c mice, the plasma testosterone 
level was significantly increased compared to the control group (Figure 5.A). Testosterone 
level in the testis was also measured. Like the plasma result, it was observed that the 
testosterone level in the testis of BALB/c mice was significantly higher in the SAC treated 
group compared to the control group (Figure 5.B). However, the Plasma level of LH hormone 
did not change significantly after SAC treatment (Figure 5.C).   
Next, the proteins involved in testosterone synthesis in the testis like PKA and CYP11A 
were analyzed by the western blot method. It was found that SAC significantly upregulated the 
phosphorylated PKA (p-PKA) where the total PKA was unchanged. Moreover, the ratio of p-
PKA to PKA was also significantly changed in the SAC treated group compared to the control 
group. On the other hand, the level of CYP11A protein was found unchanged after SAC 









Figure 5. Effect of SAC on testosterone production in BALB/c mice. (A) plasma testosterone 
(n = 6–7), (B) testis testosterone (n = 7–8) and (C) plasma luteinizing hormone (LH) (n = 6) 
were measured by ELISA. Data are presented as the mean ± SE. Data were analyzed by 

















Figure 6.  Effect of SAC on the level of PKA, p-PKA, and CYP11A proteins in the testis of 
BALB/c mice.  Proteins were measured by the western blot method. Data are shown as 




Study 2: Effect of S-allyl cysteine on testosterone production in I-10 cells. 
In this section, the molecular mechanism of testosterone synthesis stimulated by SAC 
was investigated on testosterone-producing I-10 cells.  
 
Methods and materials 
Cell culture method  
Mouse testis-derived I-10 tumor cells were purchased from the Health Science 
Research Resource Bank (Osaka, Japan). For the maintenance, cells were cultured in Ham’s F-
10 medium (Sigma-Aldrich, St. Louis, MO, USA) supplemented with 10% fetal bovine serum 
(Cosmo Bio Co., Ltd., Tokyo, Japan), 50 U/L of penicillin, and 50 mg/mL of streptomycin 
(Gibco, Thermo Fisher Scientific, Carlsbad, CA, USA) in 10 cm dish in a humidified chamber 
at 37 °C and 5% CO2. For the passaging of cells, the culture medium was removed by using an 
aspirator followed by washing the culture dish with PBS twice. Cells were detached from the 
surface using 0.25% trypsin-EDTA for 5 min. Cells were resuspended with fresh medium and 
transferred to new dishes. Cells were used in the experiment when they reached 70–80% of 
confluence. SAC was dissolved in water at a concentration of 200 mM and kept at −20 °C 
(stock solution). The stock solution was further diluted with water before mixing with the 
medium. The final concentration of water was 0.1% in the medium used for the experiments. 
Cell proliferation assay 
I-10 cells (3.6 × 104 cells) in 100 µL medium per well in 96-well plate were incubated 
overnight, followed by replacing the medium with 100 µL fresh medium containing 1, 10, and 
100 µM of SAC. After 24 h of incubation, 10 µL WST-1 reagent (Takara Bio Inc., Shiga, 
Japan) was added to each well. Absorbance at different time intervals was taken at 450 nm with 
a reference wavelength of 630 nm using a microplate reader XR (Bio-Rad, Hercules, CA, 




Testosterone measurement from I-10 cells  
I-10 cells at a density of 3.6 × 104 per well in 800 µL medium in a 12 well plate were 
incubated overnight. The next day the medium was replaced with fresh medium containing 
SAC. After 24 h of incubation with SAC, 600 µL medium was collected and centrifuged at 
1000 x g for 5 min. Testosterone was measured directly from the supernatant by ELISA method 
according to the manufacturer’s instruction. (Cayman Chemical Co., Ann Arbor, MI, USA).  
Western blot method 
I-10 cells (2 × 106  cells) in 5 mL medium in 6 cm dish were incubated overnight, 
followed by replacing the medium with 5 mL fresh medium containing SAC for 1.5 h or 6 h. 
After the indicated incubation time the medium was removed, and cells were washed with ice-
cold PBS. Next, 1 mL of ice-cold PBS was added to the dish placed on ice, and cells were 
collected in a tube using a rubber scraper. Cell suspension in the PBS was centrifuged at 1,000 
x g, 4°C for 2 min. After removing the PBS, 250 µL lysis buffer (50 mM Tris-HCl at pH 7.5, 
150 mM NaCl, 0.1% SDS, 5 mM EDTA) containing phosphatase inhibitor and protease 
inhibitor (Roche Applied Science, Mannheim, Germany) was added to the pellets and mixed 
thoroughly by pipetting. After mixing, cells with the lysis buffer were kept on ice for 20 min 
followed by centrifuging at 13,000 rpm, 4°C for 20 min. Supernatant from the cell lysate was 
collected in another tube. From the supernatant total protein concentration and different protein 
expression level was measured by Lowry method and western blot method respectively as 
described on study 1 of this chapter.  
RNA extraction method 
I-10 cells (106 cells) in 5 mL medium in 6 cm dish were incubated overnight, followed 
by replacing the medium with fresh medium containing 100 µM SAC. After 3 h of incubation, 
the medium was removed and 500 µL Isogen reagent (Nippon Gene, Tokyo, Japan) was added 
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to the dish. Isogen reagent was mixed with the cells by pipetting. The total cell lysate was 
collected using a rubber scraper to a tube. 100 µL chloroform was added to the tube and mixed 
by a vortex mixer for 15 s.  This solution was centrifuged at 13,000 rpm, 4°C for 15 min. The 
upper aqueous layer was collected to another tube and an equal volume of isopropanol was 
added. After mixing with isopropanol the solution was centrifuged at 13,000 rpm, 4°C for 10 
min. The supernatant was removed by decantation and the RNA pellet was washed with 500 
µL 75% ethanol at 13,000 rpm, 4°C for 5 min twice. After decanting the ethanol, the RNA 
pellet in the tube was air-dried for 30 min. Next DEPC treated water was mixed with the RNA 
by pipetting. RNA purity and quantity were measured spectrophotometrically using a 
NanoDrop spectrometer (NanoDrop Technologies, Wilmington, DE, USA) from the 
absorbance at 260 nm in relation to that at 280 nm. 
c DNA synthesis and mRNA quantification   
4 µg RNA was used for cDNA synthesis as a template. RNA was denatured for 5 min 
with 2.5 µM oligo-dT primer (Hokkaido System Science Co., Sapporo, Japan) and 0.5 mM 
dNTP (GE Healthcare, Tokyo, Japan) at 65 °C. From the denatured RNA, cDNA was 
synthesized using 50 U SuperScript III reverse transcriptase (Invitrogen, Carlsbad, CA, USA) 
and 20 U RNaseOUT RNase inhibitor (Invitrogen) in RT buffer (50 mM Tris-HCl at pH 8.3, 
75 mM KCl, 3 mM MgCl2, and 5 mM dithiothreitol) at 50 °C for 60 min. After completion of 
cDNA synthesis, cDNA was diluted 10 times and stored at -20°C for further analysis. 30 times 
diluted cDNA was used as a template to amplify the target sequence using gene-specific 
primers (shown in Table 1). SYBR Premix Ex Taq solution (Takara Bio, Otsu, Japan) was used 
for the quantitative RT-PCR using the CFX96 Touch Real-Time PCR Detection System (Bio-
Rad Laboratories Inc., Hercules, CA, USA). The mRNA levels were then normalized to the 
levels of eukaryotic elongation factor 1α1 (Eef1a1).  
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Measurement of cAMP 
I-10 cells were seeded at a density of 106 cells into 6 cm dish overnight followed by 
changing the medium containing 100 µM SAC for 1.5 h. After removing the medium, 1 mL 
0.1 M HCl was added to the dish and incubated at room temperature for 20 min. Cells with the 
HCl solutions were collected using a rubber scraper into a tube and centrifuged at 1000 x g for 
10 min. KOH and acetic acid anhydride were added to the supernatant for the acetylation of 
cAMP. Acetylated cAMP concentration in the cell lysate supernatant was determined by cAMP 




To investigate the direct effect of SAC on steroidogenesis, mouse testis-derived I-10 
cell line was used. First, the cytotoxic or proliferative effect of SAC was checked on I-10 cells 
using the water-soluble tetrazolium salts-1 (WST-1) assay. It was observed that SAC has no 
cytotoxic or proliferation effect at a concentration of 1–100 µM on I-10 cells after 24 h of 
incubation (Figure 7). To confirm the testosterone synthesis in I-10 cells, forskolin was used 
as a positive stimulator for steroidogenesis. After 12 h of incubation with 10 µM forskolin, the 
testosterone level in the culture medium was around 5 times higher than that of the control 
group in I-10 cells (Figure 8.A). Next, testosterone levels in I-10 cells were measured after 
SAC treatment. SAC at 10 µM significantly enhanced the testosterone level in I-10 cells. After 
100 µM SAC treatment the testosterone level was approximately two times higher than that of 
the control group (Figure 8.B). 
Next, the expression levels of PKA and p-PKA in SAC-treated I-10 cells were 
measured by western blot method to elucidate the effect of SAC on the activation of PKA in I-
10 cells after 1.5 h of incubation. It was observed that SAC did not change the PKA level but 
significantly enhanced p-PKA expression in I-10 cells (Figure 9). Additionally, other 
steroidogenic proteins like CYP11A and CREB levels were measured after 6 h of incubation 
with SAC in I-10 cells. It was found that at this time point, SAC significantly increased the 
phosphorylated CREB compared to the control group whereas the total CREB level was not 
changed. On the other hand, the CYP11A protein level was not changed at this time point by 
SAC treatment (Figure 10). 
Furthermore, after 3 h of incubation with SAC, the mRNA expression levels of StAR 
and Cyp11a were measured in I-10 cells by quantitative RT-PCR. SAC significantly increased 
the mRNA level of Cyp11a but did not change the StAR mRNA level after the indicated 
incubation time (Figure 11). In addition, the cAMP level was measured by ELISA method after 
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1.5 h of incubation with SAC in I-10 cells. However, it was found that SAC did not change the 




Table 1. Primer sequence used in the qRT-PCR. Sequences are shown as 5’→3’ direction. 
  
Gene Name Forward Primer Reverse Primer 
Cyp11a CGTGACCTTGCAGAGGTACACT GCTGGAATCTTGTAATTACGAAGCA 
StAR GGAGCTCTCTGCTTGGTTCTC TTAGCACTTCGTCCCCGTTC 










Figure 7. Effect of SAC on cell proliferation of I-10 cells by WST-1 method. n=4-5. Mean ± 








Figure 8. Effect of SAC on testosterone production in I-10 cells. A. Testosterone level after 
forskolin (Fsk) treatment for 12 h. Testosterone level after SAC treatment for 24 h.  Data are 
shown as mean ± SE. n=3. Data were analyzed by student’s t-test or Dunnett test. *P<0.05, 




















Figure 9. Effect of SAC on PKA, p-PKA protein level in I-10 cells. 100 µM SAC was treated 
on I-10 cell for 1.5 h. Proteins were measured by the western blot method. n=3. Mean ± SE. 
























Figure 10. Effect of SAC on PKA, p-PKA, CYP11A. CREB and p-CREB protein level in I-
10 cells. SAC was treated on I-10 cells for 6 h. Proteins were measured by the western blot 











Figure 11.  Effect of SAC on the mRNA level of StAR and Cyp11a genes in I-10 cells by the 








Figure 12. Effect of SAC on the intracellular cAMP level in I-10 cells by ELISA method. 100 
µM SAC was treated in I-10 cells for 1.5 h. n=3. Mean ± SE. Student’s t-test. *P<0.05.  
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Study 3: Effect of SAC on testosterone production and liver function in Wistar rat. 
In this section, the effect of SAC on Wistar rats after chronic supplementation was 
investigated. Primarily testosterone level in the plasma was analyzed, later some parameters 
associated with liver function were analyzed. 
Methods and materials 
Animal experiment 
7 week old male Wistar rats were purchased from Japan SLC, In. The rats were 
maintained in steel cages with free access to laboratory F2 diet (Funabashi Farm Co., 
Funabashi, Japan.) and tap water. After one week of acclimation, rats were separated into 2 
groups (n=8 in each group). Rats from the treatment group were given SAC by oral gavage in 
distilled water at 50 mg/kg body weight daily for 10 weeks.  Rats from the control group were 
treated with distilled water only. The final volume of distilled water given by oral gavage was 
2 mL/kg body weight. Testosterone level from the plasma was measured weekly for up to 8 
weeks. After 10 weeks of SAC supplementation, rats were sacrificed by decapacitation. Whole 
blood was immediately collected and kept at room temperature for around 15-20 min to 
coagulate. Serum was prepared by centrifuging the blood at 2,000 x g, 4°C for 15 min. Serum 
was stocked at -65°C for further analysis. Markers associated with liver function were assessed 
by Oriental Yeast Co. 
Weekly blood collection and plasma preparation 
Before collecting blood, rats were anesthetized with isoflurane.  Rats were placed on a 
heating pad at 39°C for 3-4 min. In the heating pad, the tail veins were observed for dilation. 
Blood was collected from the dilated lateral vein of the tail using a pre heparinized 26.5 G 
needle.  Plasma preparation method was the same as described in study 1 of this chapter.   
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Testosterone extraction and measurement 
Testosterone extraction and measurement methods from the plasma are the same as 
described in study 1 of this chapter.  
Western blot method  
Western blot method for determining the liver phosphorylated AMPK and total AMPK 
(Millipore) are the same as described in study 1 of this chapter.  
 
Results 
The mean plasma testosterone levels for the rats of the control up to 8 weeks were 2.0, 
2.8, 1.8, 1.7, 0.9, 1.2, 1.8, and 1.3 ng/mL, respectively. On the other hand, plasma testosterone 
levels for the SAC treated rats were 1.6, 1.9, 2.3, 2.1, 1.2, 1.2, 1.4, 1.0 ng/mL, respectively 
(Figure 13). Testosterone level for every week was analyzed by students t-test. It was found 
that there was no significant change in testosterone level after chronic administration of SAC.  
The body weight of the Wistar rat was taken every day during the experimental period. 
The weekly body weight changes are shown in Figure 14. After sacrificing the rats, the weight 
of the liver and testis were also taken (Figure 15). It was found that after chronic administration, 
SAC did not change the body, liver, and testis weight of the Wistar rat. 
Serum parameters associated with liver function were analyzed in Wistar rats after 
chronic supplementation of SAC (shown in Table 2). It was found that SAC significantly 
reduced serum levels of glucose, TG, and ALP. However, the AST level in serum was increased 
after SAC treatment. Moreover, the liver AMPK protein level was measured by western blot 
method. It was found that SAC can significantly enhance the phosphorylation of AMPK 















Figure 13. Effect of SAC on weekly testosterone level in the plasma of Wistar rat by ELISA 

















Figure 14. Effect of SAC on weekly body weight change of Wistar rat. Data are presented as 











Figure 15. Effect of SAC on testis and liver weight of Wistar rat. Data are presented as the 
mean ± SE. n=8.   
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Data are shown as mean ±SE. n=8. Data were analyzed by student’s t-test. *P <0.05 vs 
control. 
  
Parameters Control SAC 
Total Protein (g/dL) 6.75±0.105 6.53±0.056 
Albumin (g/dL) 4.688±0.069 4.662±0.026 
Albumin to globulin ratio 2.288±0.079 2.512±0.077 
Fe (μg/dL) 159.625±7.66 157.375±4.355 
AST (IU/L) 253.25±16.3 336.88±25.671(*) 
ALT (IU/L) 75.5±2.196 88.4±8.185 
ALP (IU/L) 778.00±26.349 636.25±34.341(*) 
LDH (IU/L) 1933.75±135.751 2275.00±172.047 
Leucine aminopeptidase (IU/L) 59.75±1.146 58.63±0.905 
Choline Esterase (IU/L) 12.13±1.156 11.25±0.675 
Total cholesterol(mg/dL) 78.00±2.679 78.63±2.5 
Free cholesterol (mg/dL) 19.3±0.648 18.5±0.707 
Esterified cholesterol (mg/dL) 58.75±2.085 60.13±1.95 
TG (mg/dL) 159.375±22.329 96.125±12.62 (*) 
LDL-Cholesterol(mg/dL) 4.50±0.267 4.25±0.164 
HDL-C cholesterol(mg/dL) 33.375±0.844 32.625±1.017 
Total bilirubin (mg/dL) 0.028±0.006 0.026±0.005 
Direct bilirubin (mg/dL) 0.014±0.003 0.01±0.003 
Indirect bilirubin (mg/dL) 0.014±0.005 0.016±0.005 
Total bile acid (μmol/L) 9.375±1.322 8.375±0.981 




















Figure 16. Effect of SAC on the level of p-AMPK and AMPK protein in the liver of Wistar 
rat. Western blot method.  Data are presented as the mean ± SE. n=4, Data were analyzed by 





In this study, BALB/c mice were used as an animal model to study the steroidogenic 
effect by SAC in a single dose experiment. Previous study in our lab showed that biotin and 
other food ingredients can stimulate testosterone production in BALB/c mice in a single dose 
experiment. Therefore BALB/c mice were chosen as an animal model in this study. It was 
found that after single dose administration, SAC can enhance testosterone levels both in plasma 
and testis. Testosterone synthesis depends on the secretion of luteinizing hormone to the 
circulation (LH) from the pituitary gland [38]. Therefore, LH level in the plasma of BALB/c 
mice was also measured. However, SAC did not change the LH level in plasma, suggesting the 
direct role of SAC on the testis rather than the hypothalamus-pituitary axis.  
To analyze the direct effect of SAC on steroidogenic cells, mouse testis derived I-10 
cell was used for the cell-based experiment. I-10 cell produces steroid hormones and secretes 
the hormones to the culture medium. Various natural compounds have been reported to 
stimulate steroidogenesis in I-10 cells [44,45]. Therefore, in this study I-10 cell was chosen as 
a cell model for testosterone synthesis. In this study testosterone synthesis by I-10 cells was 
confirmed by using forskolin, a positive control for steroidogenesis. It was found that SAC can 
enhance testosterone production in I-10 cells without changing cell proliferation. Collectively 
these result from animal and cell-based experiment suggest that SAC directly stimulate the 
testosterone synthesis on steroidogenic cells of the testis.  
Testosterone synthesis is firmly regulated by complex mechanisms in Leydig cells. 
PKA plays a key role in steroidogenesis as activated PKA phosphorylates various regulator 
proteins involved in steroidogenesis such as CREB and StAR. Therefore, in this study, the role 
of SAC on the level of PKA in testis and I-10 cells was investigated. It was found that SAC 
activates PKA in its phosphorylated form both in testis and I-10 cells without changing the 
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total PKA level. Classically, activation of PKA is mediated by the intracellular cAMP. 
However, for steroidogenesis, both cAMP-dependent and independent activation of PKA have 
been reported from previous studies [46]. Therefore, in this study, the intracellular cAMP level 
was measured after SAC treatment. It was found that SAC did not change the intracellular 
cAMP level after indicated incubation time. Therefore, the activation of PKA in I-10 cells by 
SAC might follow the cAMP-independent mechanism. For steroidogenesis, activated PKA 
phosphorylates CREB. Activated CREB is a transcription factor for other steroidogenic 
proteins. This study also found that SAC enhanced the level of phosphorylated CREB protein 
without changing the level of total CREB. mRNA level of Cyp11a and StAR gene were also 
measured by the qRT-PCR method. It was found that SAC can upregulate the mRNA level of 
Cyp11a but not the StAR after indicated incubation time.  
CYP11A protein (the other name is P450 cholesterol side-chain cleavage enzyme) 
catalyzes the conversion of cholesterol to pregnenolone in the mitochondria, which is the rate-
limiting step of all steroid hormone synthesis. Moreover, pregnenolone is the precursor of all 
steroid hormones. Pregnenolone and its other metabolites are considered as neurosteroids. 
Neurosteroids in the brain are essential for neuronal cell survival, proliferation, memory 
function, and cognition. Moreover, testosterone has been reported to be synthesized in the 
hippocampus [47]. As this study found that SAC affects to upregulate Cyp11a gene expression, 
therefore it is conceivable that SAC might affect the neurosteroids production in the brain.  
In the I-10 cell, this study found that SAC did not change the StAR gene expression. 
StAR is the first regulatory protein in the steroidogenic pathway that transfers cholesterol to 
the inner mitochondria. StAR protein is phosphorylated for its maximal action by PKA. A 
previous study on the steroidogenic cell model demonstrated that both phosphorylation and 
transcription of StAR are regulated by different subtypes of PKA [48]. As PKA was found to 
be upregulated in this study, it is probable that in I-10 cells, StAR protein may be regulated by 
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the phosphorylation by PKA. However, measuring the phosphorylated StAR after SAC 
treatment in I-10 cells could clarify the mechanism of how StAR is regulated by PKA in I-10 
cells for steroidogenesis.  
A recent study showed that some cysteine sulfoxides (cyclo-alliin, propenyl cysteine 
sulfoxide) from onion extract could stimulate progesterone secretion in I-10 cells via activating 
the PKA signaling pathway [45]. Similar results were also found in this study by SAC treatment 
in I-10 cells. SAC shares some structural similarities with cysteine sulfoxides. Therefore, it is 
probable that SAC could be metabolized to cysteine sulfoxides or vice versa for the 
steroidogenic effect of these compounds. In the previous study, a relatively very high 
concentration of cysteine sulfoxides (100 to 1000 µM) showed the steroidogenic effect. On the 
contrary in this study low concentration of SAC (10 to 100 µM) showed the steroidogenic 
effect. So, the chance to metabolize SAC to cysteine sulfoxides in the present cell-based study 
could be very low. Previous pharmacokinetic studies in rats and dogs revealed that a very little 
amount of SAC could be metabolized to S-allyl cysteine sulfoxide (alliin) among cysteine 
sulfoxides compounds. Moreover, alliin has not been reported yet to have a steroidogenic 
effect. Therefore, in the present animal study the chance that cysteine sulfoxides contributing 
to steroidogenesis is also very low. However, it is also probable that some cysteine sulfoxides 
and SAC could be metabolized to a common metabolite to show steroidogenic effect and acting 
as prodrugs.  
For the steroidogenic effect of SAC, PKA activation could be the most upstream 
regulator in this study. The direct activation of PKA has been suggested by various flavonoids 
for their insulinotropic effect [49]. Whether the activation of PKA by SAC is mediated by direct 
activation needs further study. As SAC is a potent antioxidant it is assumable that reducing the 
reactive oxygen species by SAC could activate PKA in this study. However, the opposite 
phenomenon was established in several studies as activation of PKA could reduce reactive 
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oxygen species. PKA has been reported to phosphorylate and inhibit the NADPH oxidases 
(NOX) in several studies to reduce the reactive oxygen species [50]. 
In the chronic dose experiment, SAC did not change the plasma testosterone level in 
the Wistar rats. However, it was found that SAC can modulate some markers associated with 
liver function. Testosterone and other steroid hormones are metabolized in the liver by phase 
1 and phase 2 reactions [51]. Therefore, it is probable that enhanced testosterone could undergo 
metabolism in the liver after chronic administration of SAC. 
Several studies on animal diseases models showed that SAC could ameliorate 
hyperglycemia and hyperlipidemia [52,53]. In this study, SAC reduced the serum TG level and 
glucose level after 10 weeks of chronic supplementation. Elevated serum level of TG is a risk 
factor for metabolic syndromes like cardiovascular diseases and hypertension. The liver is the 
primary site for lipid and glucose metabolism. AMPK is the master regulator of glucose and 
lipid metabolism via sensing the energy status. Therefore, the AMPK level in the liver was 
evaluated. SAC activated AMPK in the liver of Wistar rat without changing the total AMPK 
level. It is noteworthy that SAC and garlic extract already have been reported to activate AMPK 
in cell and animal-based studies [54,55]. Therefore, this study further strengthens the previous 
findings of the ameliorative effect of SAC on diabetes, hypertension, and cardiovascular 
diseases. 
In this study, SAC at 50 mg/kg body weight was used in both single and chronic-dose 
animal experiments. As the content of SAC in fresh garlic is very low (20-30 µg/g fresh garlic), 
consuming garlic that is usually added to food may not exert the beneficial effect suggested in 
this study. To get 50 mg/kg bodyweight concentration, a male with 70 kg body weight needs 
at least 100 kg of garlic that is not possible to consume. However, as the content of SAC in 
garlic can be increased by several chemical processing it is better to use the extracted pure 
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SAC. Moreover, SAC is already sold in many countries as a dietary supplement including in 
Japan.  
Several pharmacokinetic studies on SAC were extensively investigated on animal 
models like rats and dogs. SAC has high bioavailability, renal reabsorption, and limited 
metabolism. Furthermore, SAC from garlic in a clinical trial showed no apparent toxicity. In 
this study, it was found that long-term supplementation of SAC had not affected the body, liver, 
and testis weight. Therefore, SAC can be safely used for the treatment and prevention of 




Chapter 3: Protective effect of S-allyl cysteine in HT-22 cells from 
glutamate-induced toxicity 
 
In this chapter, the neuroprotective effect of SAC was investigated using mouse hippocampal-
derived HT-22 cells.  
 
Methods and materials 
Cell culture method: 
H-22 cells were purchased from Merck (KGaA, Darmstadt. Germany). For the 
maintenance, cells were cultured in high glucose DMEM medium (Sigma-Aldrich, St. Louis, 
MO, USA) supplemented with 10% fetal bovine serum (Biosera, Nuaillè, France), 100 U/mL 
of penicillin, and 100 µg/mL of streptomycin (Sigma-Aldrich) in 10 cm dish in a humidified 
chamber at 37°C and 5% CO2. The other cell culture conditions are the same as mentioned in 
study 2 of chapter 2. Cells were used for the experiment from the passage number between 5 
to 10. Sodium glutamate (Wako Pure Chemical Corporation, Japan) was dissolved in water at 
1M concentration and kept at 4°C for further use.  
Cell proliferation assay 
HT-22 cells were seeded in a 96 well plate at a density of 5 × 103 cells/well with 100 
µL medium. Next, cells were incubated overnight followed by changing the medium with 
various concentrations of SAC or glutamate or both for 24 h. The other methods for cell 




Western blot method 
 HT-22 cells (5 x105 cells) were incubated into 6 cm dish overnight followed by 
changing the medium containing SAC or vehicle. After 3 h of incubation with SAC, glutamate. 
was added to the culture medium at 1.5 mM concentration and incubated for 8 h. Next, the 
medium was removed, and cells were washed with ice-cold PBS. 250 µL lysis buffer (10 mM 
HEPES at pH 7.5, 150 mM NaCl, 5 mM EDTA, and 0.1% SDS) containing phosphatase 
inhibitor and protease inhibitor was added directly to the dish. Cells with the lysis buffer in the 
dish were incubated on ice for 30 min. The other methods for protein extraction and western 
blot are the same as described in study 2 of chapter 1. Membranes were incubated with 
antibodies against ERK 1/2, p-ERK1/2, p38, p-p38, cleaved caspase 3, caspase-3 (Cell 
Signaling Technology), and BDNF (Abcam, Cambridge, UK).  
 
Results 
First, the cell proliferation of HT-22 cells by SAC was investigated by WST-1 method. 
SAC at 0, 1, 5,10, 20, 40 and 80 µM concentration was incubated for 24 h in HT-22 cell. The 
relative mean cell proliferation for the groups were 100.00, 109.67, 116.58, 113.33, 
114.32,113.00, 104.90, and 108.21%, respectively (Figure 17.A). It was observed that SAC at 
these concentrations did not significantly change the cell proliferation of HT-22 cells. Cell 
proliferation was also measured after only glutamate treatment for 24 h incubation. The cell 
proliferation after 0, 1, 2, 3 mM glutamate treatment were 100.00, 60.46, 22.12, and 3.62% 
respectively (Figure 17.B). It was found that glutamate significantly decreased the cell 
proliferation dose-dependently. Next, HT-22 cells were co-treated with 1.5 mM glutamate and 
20 to 80 µM SAC for 24 h. After only the glutamate challenge the cell proliferation 
significantly decreased from100.00% to 29.30%. The reduced cell proliferation is further 
enhanced by 20, 40, and 80 µM SAC to 34.70, 45.55, and 51.97% respectively (Figure 18). 
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The MAPK proteins like ERK1/2 and p38 proteins were analyzed by western blot method after 
8 h of glutamate challenge in HT-22 cell. 1.5 mM glutamate significantly upregulated the 
phosphorylated ERK1/2, whereas 3 h preincubation with SAC at 40 and 80 µM significantly 
downregulated this level. A similar result was also found for the p-38 protein level (Figure 19). 
Furthermore, brain-derived neurotrophic factor (BDNF) protein level by western blot was 
measured. Glutamate significantly enhanced the pre-BDNF level and decreased the mature 
BDNF level. SAC significantly reversed the BDNF level in HT-22 cells (Figure 20). 
Glutamate-induced cell death was reported to be mediated by the caspase 3 dependent 
apoptosis pathway. Therefore, the caspase 3 level was measured to clarify the type of cell death 
after 8 h of glutamate challenge in HT-22 cells. Cleaved caspase 3 protein was not detected at 














Figure 17. Cell proliferation assay by WST-1 method in HT-22 cells. SAC or glutamate was 
treated in I-10 cells for 24 h. A. n=6. B. n=4. Data are shown as mean ± SE. Data were analyzed 


















Figure 18. Cell proliferation of HT-22 cells. WST-1 method. SAC and glutamate were treated 































Figure 19. MAPK protein level in HT-22 cells. Western blot method. n=3. Mean ± SE. Tukey 






















Figure 20. BDNF protein level in HT-22 cells. Western blot method. n=3. Mean ± SE. Tukey 




























HT-22 cell is a popular neuronal cell model to investigate glutamate-induced 
neurotoxicity. Therefore, in this study HT-22 cell was chosen as a cell model to investigate the 
role of SAC on neuronal cell survival. Similar to the previous studies this study also found that 
glutamate dose-dependently reduced the cell proliferation of HT-22 cells. Furthermore, this 
study found that SAC protected the HT-22 cell from glutamate-induced toxicity where SAC 
did not show any cytotoxic effect.  
Mitogen-activated protein kinases (MAPK) like ERK, p38, and JNK are serine-
threonine protein kinases that are activated by various stimuli like growth factors or stress in 
the neuronal cells of the central nervous system. Both the survival and apoptosis of neural cells 
by MAPKs were reported [56]. In HT-22 cells several studies demonstrated that glutamate 
stimulated the MAPKs and persistent activation of MAPKs induces cell death [39]. In 
agreement with the previous findings, this study also found that glutamate upregulated the 
phosphorylation of ERK1/2 and p38 proteins. Furthermore, SAC inhibited the activation of 
these proteins. Previous studies already demonstrated that SAC could inhibit MAPKs proteins 
in culture neurons or brain tissues upon various stresses [57]. Reactive oxygen species were 
reported as a stimulator of MAPKs in HT-22 cells. As SAC is an antioxidant, inhibition of 
MAPKs is probably attained by reducing the reactive oxygen species in HT-22 cells.  
Brain-derived neurotrophic factor (BDNF) is a key regulatory protein in the central 
nervous system to promote the cell survival, differentiation, and plasticity of neurons during 
development. The level of BDNF has been reported to be reduced in various pathological 
conditions such as Alzheimer’s disease, Parkinson's disease, and Huntington's disease. 
Hippocampus is the major site for BNDF synthesis in the brain and participates in memory 
function and cognition. BDNF protein undergoes several translational modifications after 
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synthesizing transcriptionally and translationally. The active or mature form of BDNF 
(mBDNF) is produced from its precursor pro-BDNF. While mBDNF has a protective effect on 
neurons, the pro-BDNF is involved in neuronal apoptosis [58]. Previous study on HT-22 cells 
showed that glutamate-induced oxidative stress suppressed mBDNF production [59,60]. 
Therefore, in this study, the protein level of BDNF was measured. It was found that the pro-
BDNF level was increased after glutamate treatment where the mBDNF level was decreased. 
Treatment with SAC significantly reversed this effect, Therefore, the protection of HT-22 cells 
by SAC might be attributed to the processing of BDNF. A recent study also suggested that 
SAC could restore BDNF in rat cortical slices after oxidative stress [61].  
A previous pharmacokinetic study on rats revealed that SAC can readily cross the 
blood-brain barrier [62]. A previous study also suggested that SAC can enter to cell via alanine 
serine cysteine transporter 1 [63]. Taken together, from this study it can be concluded that SAC 




Chapter 4: Conclusion 
 
The present study aimed to identify novel beneficial effects of a garlic-derived 
compound, S-allyl cysteine (SAC), for the amelioration of age-related diseases. For this 
purpose, testosterone synthesis and neuroprotective effect by SAC were investigated by using 
animals and cell models.  
For the study of testosterone synthesis by SAC, BALB/c mice and Wistar rats were 
used as animal models whereas mouse testis-derived I-10 cells were used as cell models. In 
BALB/c mice, SAC enhanced testosterone level both in plasma and testosterone-producing 
organ testis after a single dose administration. SAC also enhanced testosterone production in 
I-10 cells without any cytotoxicity. SAC activated the PKA, essential for the steroidogenesis, 
in both I-10 cells and testis of BALB/c mice although SAC did not affect the intracellular 
cAMP level in I-10 cells. SAC also activated the CREB, the target of PKA, in I-10 cells. 
Furthermore, SAC enhanced the expression of the Cyp11a gene in I-10 cells. CYP11A protein 
is the first rate-limiting enzyme for all steroid hormone synthesis. Thus, the cAMP-independent 
activation of PKA might be responsible for the enhancement of testosterone by SAC. However, 
after chronic supplementation of SAC in Wistar rats, the testosterone level in the plasma 
remained unchanged. Additionally, SAC showed reducing the level of glucose and TG in the 
serum of these rats, activated liver AMPK, suggesting its role to improve age-related metabolic 
syndrome. 
For the study of neuroprotection by SAC, mouse hippocampal-derived HT-22 cell 
model, widely used for glutamate-induced neurotoxicity, was investigated. Glutamate dose-
dependently reduced the cell viability of HT-22 cells. This cytotoxicity was further improved 
by SAC. SAC also inhibited the glutamate-induced activation of ERK1/2 and p38 MAPK 
proteins that are responsible for the cell death of HT-22 cells. Furthermore, SAC upregulated 
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the mBDNF protein after glutamate-induced suppression, suggesting its role to protect 
neuronal cells via the BDNF signaling pathway.   
In conclusion, this study shows that SAC has the potential to improve testosterone 
decline in males and to prevent glutamate-induced toxicity. SAC has a therapeutic potential to 
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